Medicine News and Research

RSS

AI tool could help identify life-threatening transplant complications

A powerful artificial intelligence (AI) tool could give clinicians a head start in identifying life-threatening complications after stem cell and bone marrow transplants, according to new research from MUSC Hollings Cancer Center.

16 Feb 2026

Study reveals persistent gaps in child mental health access

A new study led by the Harvard Pilgrim Health Care Institute finds that mental health care gaps for U.S. children remain stark: one in five households reported a child needing treatment, yet nearly a quarter didn't receive it, and many who did still struggled to access care.

16 Feb 2026

Chronic inflammation shapes cancer progression and immunotherapy response

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

16 Feb 2026

Dysplasia grade predicts colorectal cancer risk in people with IBD

People with inflammatory bowel disease (IBD) and precancerous colorectal lesions are much more likely to develop colorectal cancer, a new study shows.

16 Feb 2026

CNN-based system improves lung nodule detection and classification

Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

16 Feb 2026

OVACell project pioneers viral target immunotherapy for ovarian cancer

A small team at OVACell is fighting ovarian cancer with hidden viral sequences and advanced immunotherapies.

16 Feb 2026

Unlocking the potential of phytochemicals in rheumatoid arthritis treatment

Announcing a new article publication for BIO Integration journal. In recent years, phytochemicals and medicinal plants have increasingly been used to treat autoimmune diseases, such as rheumatoid arthritis (RA).

16 Feb 2026

HER2 gastric cancer: Unraveling resistance at single-cell resolution

HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies.

16 Feb 2026

Synergistic drug pair shows promise for spinal cord injury recovery

Spinal cord injury remains one of the most challenging neurological conditions to treat, largely because damage continues to worsen long after the initial trauma.

16 Feb 2026

Survey: 76% of surgical patients don't complete physical therapy homework, leading to stalled recoveries

Physical therapy is a key step on the path to recovery after injuries or certain surgical procedures. A new survey by The Ohio State University Wexner Medical Center shows 3 out of 4 (76%) patients don't complete their physical therapy homework, leading to stalled recoveries and potential surgical setbacks.

16 Feb 2026

Aptar Pharma’s intranasal solutions power CastleVax Phase II clinical trials for next-gen COVID-19 vaccine

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are being utilized in CastleVax’s Phase II clinical trial for CVAX-01, an intranasal COVID-19 vaccine candidate.

From Hanson Wade Group - 4th Nasal Formulation & Delivery Summit 16 Feb 2026

Innate immune priming may evolve into a broadly applicable infection-prevention strategy

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine.

16 Feb 2026

Global study reveals disparities in early-onset gastric cancer

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases—diagnosed before age 50—display unique biological and clinical patterns.

16 Feb 2026

Schools and families may not be fully prepared to respond to teen cardiac emergencies

Sudden cardiac arrest can happen to anyone, including teens, and a new national poll suggests many schools and families may not be fully prepared to respond.

16 Feb 2026

Study explores how reversible RNA editing could transform future cardiovascular medicine

This mini-review synthesises evidence showing that adenosine-to-inosine RNA editing plays an important regulatory role in cardiovascular development, cellular homeostasis, and disease biology. It highlights emerging links between dysregulated RNA editing and cardiovascular conditions while outlining biomarker potential and reversible RNA-editing therapeutic strategies that remain under investigation.

15 Feb 2026

Role of food nutrients in reducing oxidative stress linked to micro- and nanoplastics

This narrative review examines how micro- and nanoplastics may contribute to oxidative stress, inflammation, and metabolic dysfunction, including potential links with diabetes. It highlights plant-derived nutrients that activate the Nrf2 pathway as a possible strategy to enhance cellular stress resilience, although most evidence remains preclinical.

15 Feb 2026

Global trends shape progress in cell and gene therapies

Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the transplantation of living cells -- and gene therapy -- the use of genetic material to modify cell functions -- have been increasingly incorporated into clinical practice.

13 Feb 2026

Review compares surgical and neurostimulation outcomes in temporal lobe epilepsy

Temporal lobe epilepsy (TLE) is the most common form of focal epilepsy, affecting a significant proportion of patients who develop drug-resistant epilepsy.

13 Feb 2026

Diabetic nephropathy shows severe biochemical abnormalities

Chronic diabetes mellitus is marked by hyperglycemia and metabolic dysfunction, increasing the risk of complications such as nephropathy.

13 Feb 2026

Parenting style shapes adolescent alcohol and drug use

"Like father, like son? Can parenting styles break the intergenerational pattern of alcohol and drug use?" A group of Brazilian researchers analyzed data on the behavior of 4,280 adolescents and their guardians based on this question, arriving at two important conclusions.

13 Feb 2026